GEPIRONE ER - AN EFFICACY AND SAFETY TRIAL IN MAJOR DEPRESSIVE DISORDER

被引：0
|
作者：
CUTLER, NR
JENKINS, S
SRAMEK, JJ
DOSS, MG
PRESTON, TV
机构：
[1] CALIF CLIN TRIALS,BEVERLY HILLS,CA 90211
[2] BRISTOL MYERS SQUIBB CO,WALLINGFORD,CT 06492
来源：
BIOLOGICAL PSYCHIATRY | 1993年 / 33卷 / 6A期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：A82 / A82
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder
    Kamath, Jayesh
    DeMartinis, Nicholas
    Handratta, Venkatesh
    FUTURE NEUROLOGY, 2007, 2 (04) : 361 - 371
  • [22] EFFICACY TRIAL OF A-75200 IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    CUTLER, NR
    SRAMEK, JJ
    KASKIN, K
    GREBB, J
    KENNEDY, S
    SADD, C
    BIOLOGICAL PSYCHIATRY, 1994, 35 (09) : 679 - 679
  • [23] Efficacy and safety of agomelatine given orally in children and adolescents with major depressive disorder: a randomized controlled trial
    Olivier, V.
    Marx, U.
    Picarel-Blanchot, F.
    Penelaud, P. F.
    De Bodinat, C.
    Falissard, B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S186 - S187
  • [24] The efficacy and safety of levomilnacipran in the treatment of major depressive disorder: Results from a phase III clinical trial
    Bose, A.
    Chen, C.
    Gommoll, C.
    Ruth, A.
    Hussainzada, N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 182 - 182
  • [25] The efficacy and safety of levomilnacipran in the treatment of major depressive disorder: results from a phase III clinical trial
    Bose, A.
    Chen, C.
    Gommoll, C.
    Ruth, A.
    Terner-Rosenthal, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S261 - S262
  • [26] Does gepirone-ER have a pro-sexual effect in men with major depressive disorder MDD and sexual dysfunction?
    Fabre, L. F.
    Kramer, S. J.
    Smith, L. C.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 423 - 423
  • [27] An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder
    Carrasco, Jose L.
    Kornstein, Susan G.
    McIntyre, Roger S.
    Fayyad, Rana
    Prieto, Rita
    Salas, Maribel
    Mackell, Joan
    Boucher, Matthieu
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2016, 31 (03) : 134 - 146
  • [28] EFFICACY, SAFETY, AND TOLERABILITY CONSIDERATIONS IN THE NOVEL TREATMENT OF MAJOR DEPRESSIVE DISORDER
    Nierenberg, Andrew
    Kennedy, Sidney
    Lydiard, R. Bruce
    Rapaport, Mark Hyman
    CNS SPECTRUMS, 2009, 14 (03) : 1 - +
  • [29] An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder
    Carrasco, J.
    Kornstein, S.
    McIntyre, R. S.
    Fayyad, R.
    Prieto, R.
    Salas, M.
    Mackell, J.
    Boucher, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S398 - S398
  • [30] A Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder
    Komaram, Ravi Babu
    Nukala, Srikrishna
    Palla, Jayasree
    Nambaru, Lakshmana Rao
    Kasturi, Satyanarayana Murthy
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (06) : VC5 - VC8
12345